The HOPE study and diabetes (multiple letters)

Lancet

Volumn 355, Issue 9210, 2000, Pages 1181-1184

  Jensen, T ^a   Webster, M W I ^a   Lewis, V ^a   Kloer, P ^a   Prasad, N ^a   Alcolado, J C ^a   Fegan, G ^a   Ward, D ^a   Clarke, L ^a   MacLeod, K ^a   Hattersley, A ^a   Stubanus, M ^a   Endemann, D ^a   Fischereder, M ^a   Ittner, K P ^a   Kramer, B K ^a   Gerstein, H C ^a   Yusuf, S ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HYPERTENSION; KIDNEY DISEASE; LETTER; PRIORITY JOURNAL; HUMAN; NOTE; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; HUMANS; HYPERTENSION; RAMIPRIL; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES;

EID: 0034165013     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02076-6     Document Type: Letter

References (0)